Global Medical Pendant Market to Surpass $775.1 Million by 2027, Growing at a CAGR of 8.1% During COVID-19 Pandemic | Published by Research Dive
07 sept. 2022 09h01 HE
|
Research Dive
New York, USA, Sept. 07, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global medical pendant market is anticipated to register a revenue of $775.1 million by...
Brave of Heart Fund relieves hardships of families grieving deceased COVID-19 healthcare workers
06 sept. 2022 10h25 HE
|
E4E Relief; Brave of Heart Fund
CHARLOTTE, N.C., Sept. 06, 2022 (GLOBE NEWSWIRE) -- More than 900 families facing extraordinary personal, financial, and psychological losses from COVID-19 found support and hope from the Brave of...
Global Tissue Diagnostic Markets, 2016-2021, 2021-2026F, 2031F: Consumables, Antibodies, Kits, Reagents, Probes, Instruments, Slide Staining System, Scanner, & Tissue Processing System
05 sept. 2022 05h33 HE
|
Research and Markets
Dublin, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The "Tissue Diagnostic Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global tissue diagnostic market is...
Global Urea Breath Test Market Report (2022 to 2030) - by Test Type, Product, Instrument, End-user, and Region
31 août 2022 08h13 HE
|
Research and Markets
Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The "Urea Breath Test Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering. The...
DTP Vaccines Global Market Report 2022: Key Players Merck, Novartis, Pfizer & Others Driving 6.8% Annual Growth
24 août 2022 05h53 HE
|
Research and Markets
Dublin, Aug. 24, 2022 (GLOBE NEWSWIRE) -- The "DTP Vaccines Global Market Report 2022: By Product, By Disease, By End-User" report has been added to ResearchAndMarkets.com's offering. The global...
Pfizer und BioNTech geben Update zur Wirksamkeit ihres COVID-19-Impfstoffs bei Kindern von 6 Monaten bis 4 Jahren
23 août 2022 06h45 HE
|
BioNTech SE
Daten einer weiterführenden Analyse mit 34 Fällen, die mindestens sieben Tage nach Verabreichung der primären Impfserie bestehend aus drei Dosen auftraten, zeigen eine Impfstoffwirksamkeit von 73,2 %...
Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
23 août 2022 06h45 HE
|
BioNTech SE
Updated analysis from 34 cases occurring at least seven days following a three-dose regimen showed 73.2% vaccine efficacy among children ages 6 months through 4 yearsThe vaccine efficacy remained...
Pediatric Vaccine Global Market Report 2022: Demand for Novel Vaccines Providing Immunization Against Both Infectious & Non-Communicable Diseases Presents Opportunities
23 août 2022 05h23 HE
|
Research and Markets
Dublin, Aug. 23, 2022 (GLOBE NEWSWIRE) -- The "Pediatric Vaccine Global Market Report 2022: By Vaccine, By Technology, By Application" report has been added to ResearchAndMarkets.com's offering. The...
Pfizer und BioNTech reichen Antrag für Notfallzulassung eines angepassten bivalenten COVID-19-Impfstoffs für Omikron-Varianten BA.4/BA.5 bei der FDA ein
22 août 2022 10h30 HE
|
BioNTech SE
Die Daten stützen Antrag auf Notfallzulassung einer 30-µg-Auffrischungsdosis eines an Omikron BA.4/BA.5 angepassten bivalenten COVID-19-Impfstoffs für Personen ab 12 JahrenDie Unternehmen haben die...
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine
22 août 2022 10h30 HE
|
BioNTech SE
Data support request for Emergency Use Authorization of a 30-µg booster dose of an Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for individuals 12 years of age and olderCompanies have rapidly...